Skip to main content
Log in

Cyclooxygenase-2 in normal, hyperplastic and neoplastic follicular cells of the human thyroid gland

  • Original Article
  • Published:
Virchows Archiv Aims and scope Submit manuscript

Abstract

This study was undertaken to investigate cyclooxygenase-2 (COX-2) expression in follicular cells of the human thyroid. COX-2 expression was studied immunohistochemically in a total of 174 samples. COX-2 immunoreactivity was confined to the cell cytoplasm with the nuclei remaining unlabelled. COX-2 expression was observed in five cases (17.2%) of normal follicular cells and in one case (16.6%) of solid cell nests. Follicular carcinoma expressed COX-2 more frequently than follicular adenoma (93.4% vs 21.1%) (p≤0.001). A higher percentage of cases of papillary microcarcinomas up-regulated COX-2 in comparison with all papillary carcinomas (p≤0.05). However, we could not establish any relationships among COX-2, patients’ ages or lymph node metastases in papillary carcinomas. COX-2 expression was found in 12 (92.3%) poorly differentiated carcinomas and in 13 (92.8%) undifferentiated carcinomas. We found that COX-2 is not always useful as a marker of malignancy. Our results suggest that COX-2 plays a role in progression of all thyroid carcinomas, but in papillary carcinomas, seems more important only in the early stages. COX-2 expression in the undifferentiated carcinoma deserves special consideration due to its prognosis and to the fact that selective COX-2 inhibitors were found to enhance tumour response to radiation in some studies.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Agoff SN, Brentnall TA, Crispin DA, Taylor SL, Raaka S, Haggitt RC, Reed MW, Afonina IA, Rabinovitch PS, Stevens AC, Feng Z, Bronner MP (2000) The role of cyclooxygenase-2 in ulcerative colitis-associated neoplasia. Am J Pathol 157:737–745

    CAS  PubMed  Google Scholar 

  2. Boolbol SK, Dannenberg AJ, Chadburn A, Martucci C, Guo XJ, Ramonetti JT, Abreu-Goris M, Newmark HL, Lipkin ML, DeCosse JJ, Bertagnolli MM (1996) Cyclooxygenase-2 overexpression and tumor formation are blocked by sulindac in a murine model of familial adenomatous polyposis. Cancer Res 56:2556–2560

    Google Scholar 

  3. Cameselle-Teijeiro J, Chan JKC (1999) Cribriform-morular variant of papillary carcinoma: a distinctive variant representing the sporadic counterpart of familial adenomatous polyposis-associated thyroid carcinoma? Mod Pathol 12:400–411

    CAS  PubMed  Google Scholar 

  4. Cameselle-Teijeiro J, Ruiz-Ponte C, Loidi L, Suárez-Peñaranda JM, Baltar J, Sobrinho-Simoes M (2001) Somatic but not germline mutation of the APC gene in a case of cribriform-morular variant of papillary thyroid carcinoma. Am J Clin Pathol 115:486–493

    Article  CAS  PubMed  Google Scholar 

  5. Cornetta AJ, Russell JP, Cunnane M, Keane WM, Rothstein JL (2002) Cyclooxygenase-2 expression in human thyroid carcinoma and Hashimoto’s thyroiditis. Laryngoscope 112:238–242

    Article  CAS  PubMed  Google Scholar 

  6. Chan JKC (2000) Tumors of the thyroid and parathyroid glands. In: Fletcher CDM (ed) Diagnostic histopathology of tumors, 2nd edn. Churchill Livingstone, Edinburgh, Scotland pp 959–1056

    Google Scholar 

  7. Cheuk W, Chan JK (2004) Subcellular localization of immunohistochemical signals: knowledge of the ultrastructural or biologic features of the antigens helps predict the signal localization and proper interpretation of immunostains. Int J Surg Pathol 12:185–206

    CAS  PubMed  Google Scholar 

  8. DuBois RN (2000) Review article: cyclooxygenase—a target for colon cancer prevention. Aliment Pharmacol Ther 14(Suppl 1):64–67

    Google Scholar 

  9. Farrow DC, Vaughan TL, Hansten PD, Stanford JL, Risch HA, Gammon MD, Chow WH, Dubrow R, Ahsan H, Mayne ST, Schoenberg JB, West AB, Rotterdam H, Fraumeni JF Jr, Blot WJ (1998) Use of aspirin and other nonsteroidal anti-inflammatory drug and risk of esophageal and gastric cancer. Cancer Epidemiol Biomarkers Prev 7:97–102

    Google Scholar 

  10. Fosslien E (2000) Molecular pathology of cyclooxygenase-2 in neoplasia. Ann Clin Lab Sci 30:3–21

    Google Scholar 

  11. Hashimoto Y, Kondo Y, Kimura G, Matsuzawa I, Sato S, Ishizaki M, Imura N, Akimoto M, Hara S (2004) Cyclooxygenase-2 expression and relationship to tumour progression in human renal cell carcinoma. Histopathology 44:353–359

    Article  CAS  PubMed  Google Scholar 

  12. Ito Y, Yoshida H, Nakano K, Takamura Y, Miya A, Kobayashi K, Yokozawa T, Matsuzuka F, Matsuura N, Kuma K, Miyauchi A (2003) Cyclooxygenase-2 expression in thyroid neoplasms. Histopathology 42:492–497

    Article  CAS  PubMed  Google Scholar 

  13. Kelley DJ, Mestre JR, Subbaramaiah K, Sacks PG, Schantz SP, Tanabe T, Inoue H, Ramonetti JT, Dannenberg AJ (1997) Benzo[a]pyrene up-regulates cyclooxygenase-2 gene expression in oral epithelial cell. Carcinogenesis 18:795–799

    Article  CAS  PubMed  Google Scholar 

  14. Koga H, Sakisaka S, Ohishi M, Kawaguchi T, Taniguchi E, Sasatomi K, Harada M, Kusaba T, Tanaka M, Kimura R, Nakashima Y, Nakashima O, Kojiro M, Kurohiji T, Sata M (1999) Expression of cyclooxygenase-2 in human hepatocellular carcinoma: relevance to tumor dedifferentiation. Hepatology 29:688–696

    Article  CAS  PubMed  Google Scholar 

  15. Liao Z, Milas L, Komaki R, Stevens C, Cox JD (2003) Combination of a COX-2 inhibitor with radiotherapy or radiochemotherapy in the treatment of thoracic cancer. Am J Clin Oncol 26:S85–S91

    Article  PubMed  Google Scholar 

  16. Nikiforov YE, Erickson LA, Nikiforova MN, Caudill CM, Lloyd RV (2001) Solid variant of papillary thyroid carcinoma: incidence, clinical-pathologic characteristics, molecular analysis, and biologic behavior. Am J Surg Pathol 25:1478–1484

    Article  CAS  PubMed  Google Scholar 

  17. Nose F, Ichikawa T, Fujiwara M, Okayasu I (2002) Up-regulation of cyclooxygenase-2 expression in lymphocytic thyroiditis and thyroid tumors: significant correlation with inducible nitric oxide synthase. Am J Clin Pathol 117:546–551

    Article  CAS  PubMed  Google Scholar 

  18. Oshima M, Dinchuk JE, Kargman SL, Oshima H, Hancock B, Kwong E, Trzaskos JM, Evans JF, Taketo MM (1996) Suppression of intestinal polyposis in Apc delta716 knockout mice by inhibition of cyclooxygenase-2 (COX-2). Cell 87:803–809

    Article  CAS  PubMed  Google Scholar 

  19. Preto A, Cameselle-Teijeiro J, Moldes-Boullosa J, Soares P, Cameselle-Teijeiro JF, Silva P, Reis-Filho JS, Reyes-Santias RM, Alfonsin-Barreiro N, Forteza J, Sobrinho-Simoes M (2004) Telomerase expression and proliferative activity suggest a stem cell role for thyroid solid cell nests. Mod Pathol 17:819–826

    Article  CAS  PubMed  Google Scholar 

  20. Sano H, Kawahito Y, Wilder RL, Hashiramoto A, Mukai S, Asai K, Kimura S, Kato H, Kondo M, Hla T (1995) Expression of cyclooxygenase-1 and -2 in human colorectal cancer. Cancer Res 55:3785–3789

    Google Scholar 

  21. Siironen P, Ristimaki A, Nordling S, Louhimo J, Haapiainen R, Haglund C (2004) Expression of COX-2 is increased with age in papillary thyroid cancer. Histopathology 44:490–497

    Article  CAS  PubMed  Google Scholar 

  22. Soslow RA, Dannenberg AJ, Rush D, Woerner BM, Khan KN, Masferrer J, Koki AT (2000) COX-2 is expressed in human pulmonary, colonic, and mammary tumors. Cancer 89:2637–2645

    Google Scholar 

  23. Specht MC, Tucker ON, Hocever M, Gonzalez D, Teng L, Fahey TJ III (2002) Cyclooxygenase-2 expression in thyroid nodules. J Clin Endocrinol Metab 87:358–363

    Article  CAS  PubMed  Google Scholar 

  24. Subbaramaiah K, Telang N, Ramonetti JT, Araki R, DeVito B, Weksler BB, Dannenberg AJ (1996) Transcription of cyclooxygenase-2 is enhanced in transformed mammary epithelial cells. Cancer Res 56:4424–4429

    Google Scholar 

  25. Sung JJ, Leung WK, Go MY, To KF, Cheng AS, Ng EK, Chan FK (2000) Cyclooxygenase-2 expression in Helicobacter pylori-associated premalignant and malignant gastric lesions. Am J Pathol 157:729–735

    CAS  PubMed  Google Scholar 

  26. Tiano H, Chulada P, Spalding J, Lee C, Loftin C, Mahler J, Morham S, Langenbach R (1997) Effects of cyclooxygenase deficiency on inflammation and papilloma development in mouse skin. Proc Am Assoc Cancer Res 38:1727

    Google Scholar 

  27. Tucker ON, Dannenberg AJ, Yang EK, Fahey TJ III (2004) Bile acids induce cyclooxygenase-2 expression in human pancreatic cancer cell lines. Carcinogenesis 25:419–423

    Article  CAS  PubMed  Google Scholar 

  28. Urano M, Abe M, Kuroda M, Mizoguchi Y, Horibe Y, Kasahara M, Tanaka K, Sudo K, Hirasawa Y (2001) Warthin-like tumor variant of papillary thyroid carcinoma: case report and literature review. Pathol Int 51:707–712

    Article  CAS  PubMed  Google Scholar 

  29. Vane JR, Bakhle YS, Botting RM (1998) Cyclooxygenases 1 and 2 Annu Rev Pharmacol Toxicol 38:97–120

    Article  CAS  PubMed  Google Scholar 

  30. Vidal S, Kovacs K, Bell D, Horvath E, Scheithauer BW, Lloyd RV (2003) Cyclooxygenase-2 expression in human pituitary tumors. Cancer 97:2814–2821

    Google Scholar 

  31. Xu B, Yoshimoto K, Miyauchi A, Kuma S, Mizusawa N, Hirokawa M, Sano T (2003) Cribriform-morular variant of papillary thyroid carcinoma: a pathological and molecular genetic study with evidence of frequent somatic mutations in exon 3 of the beta-catenin gene. J Pathol 199:58–67

    Article  PubMed  Google Scholar 

  32. Xu XC (2002) COX-2 inhibitors in cancer treatment and prevention, a recent development. Anticancer Drugs 13:127–137

    Google Scholar 

  33. Yoshimura R, Sano H, Masuda C, Kawamura M, Tsubouchi Y, Chargui J, Yoshimura N, Hla T, Wada S (2000) Expression of cyclooxygenase-2 in prostate carcinoma. Cancer 89:589–596

    Google Scholar 

  34. Zimmermann KC, Sarbia M, Weber AA, Borchard F, Gabbert HE, Schror K (1999) Cyclooxygenase-2 expression in human esophageal carcinoma. Cancer Res 59:198–204

    Google Scholar 

Download references

Acknowledgements

The authors are grateful to Dora C. Insua Santamaría for technical assistance. We also thank Deborah L. Randall for her linguistic supervision. This work was supported by research grant (PGIDE99PXI90201B) sponsored by Xunta de Galicia, Spain.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to José Cameselle-Teijeiro.

Rights and permissions

Reprints and permissions

About this article

Cite this article

García-González, M., Abdulkader, I., Boquete, A.V. et al. Cyclooxygenase-2 in normal, hyperplastic and neoplastic follicular cells of the human thyroid gland. Virchows Arch 447, 12–17 (2005). https://doi.org/10.1007/s00428-005-1235-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00428-005-1235-1

Keywords

Navigation